Tech Digest

Hurricane Maria Is Killing Puerto Rico’s Golden Goose, but It Was Already Dying

Stay Up to Date!

Simply enter your email below and click SIGN UP!

From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here

October 9, 2017

Dear Reader,

Puerto Rico is America’s drug factory. Most major pharmaceutical companies have facilities there. This includes Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Procter & Gamble, and Wyeth. Hurricane Maria has nearly shut it down.

FDA chief Dr. Scott Gottlieb has said that his agency is working to prevent shortages of 40 crucial drugs produced on the island. They include stroke-prevention and childhood leukemia drugs. The FDA has taken the unprecedented step of helping drug companies get fuel for emergency generators.

Power outages aren’t the only problem that could affect production for months. Many employees can’t make it back to work. Transportation needed for raw materials and product shipping is crippled.

Infrastructure Is Key to Survival

After hurricanes hit, our efforts tend to focus on emergency aid. This is understandable. But the most effective help for those who live in storm-prone areas is preparation.

I’m not talking about hurricane “prep” like storing non-perishable food and bottled water. I’m talking about planning and investment in infrastructures hardened for natural disaster. But for that you need a fairly competent government.

Puerto Rico, like pre-Katrina New Orleans, wasn’t prepared. Instead, politicians spent money on programs that would get them reelected. They put resources into lavish pensions for the politically powerful public employee unions.

Even before Maria, the island was more than $70 billion in debt. Almost $50 billion of that debt is the unfunded portion of pension obligations to the growing retired population.

The biggest bill payer in Puerto Rico is pharma. It accounts for more than half the territory’s manufacturing and 25% of its GDP. The New York Times reports that the industry employs about 100,000 people. These workers make nearly three-quarters of the territory’s exports.

Drug companies wanted improved infrastructure. Blackouts are a danger to an industry that needs low temperatures to produce goods. This was an issue even before Maria. Though the industry pays much of the island’s taxes, it lacked the political clout needed to get those changes.

The Demographic Disaster

The real clout belongs to the 200,000 government employees and many more retirees living on government pensions. Puerto Rico’s largest public pension, Employee Retirement System (ERS), supports almost 100,000 retirees.

ERS runs out of cash next year. It also owes more than $3 billion to bondholders who bought debt that was supposed to bail out the failing fund.

The other side of this demographic disaster is the shrinking population of young workers. As services and infrastructure deteriorated to pay for government retirees, the economy slowed.

Desperate for opportunity, young families have fled. While the aged population increased, total population fell. The growing cost of the aged fell on a shrinking younger population.

As Megan McArdle points out in Bloomberg View, more Puerto Ricans were living in the US proper than on the island by 2008. Since then, the shift has continued. In 2014 alone, almost 3.5% of young Puerto Ricans left for the mainland.

McArdle’s article is aptly titled, “Debt Alone Won't Crush Puerto Rico. Depopulation Is the Curse.” Now, to escape dire post-hurricane conditions, hundreds of thousands more will join families in Florida and the Northeast. In fact, many will stay, returning only on vacations.

Puerto Rico was already in an economic death spiral. Hurricane Maria adds energy to that vortex.

Pharmaceutical companies were attracted to Puerto Rico at first by tax incentives for US-based drug manufacturers. But those incentives expired long ago. Taxes are sure to go up as the island struggles to pay pensions it can’t afford and recover from the storm. At the same time, skilled tax-paying labor is shrinking due to out-migration. 

I don’t think that pharmaceutical production levels will be restored to pre-hurricane levels. This will further reduce tax revenues, making the pension crisis worse.

All of this was foreseeable. Much of this was preventable. It was no surprise that a big hurricane would hit Puerto Rico. We knew it was coming even if we didn’t know when it would arrive. We also knew that the island’s demographic and political problems would result in a pension crisis.

Puerto Rico is not unique in this. It’s just ahead of the curve. Most American states are headed for the same demographic cliff. California, Illinois, New Jersey, and Kentucky are leading the charge.

As it happens, Hurricane Maria coincided with Puerto Rico’s demographic storm. It is ironic that it will almost certainly help kill (or at least cripple) pharmaceutical manufacturing.

It’s doubly ironic that the only solution for the demographic collapse must come from pharma. Specifically, the answer is anti-aging therapies that can keep older people productive and healthy for much longer.

On a personal note, I should mention that I wasted much of my life as a policy economist. Back then, I thought that government policies could be changed to prevent Social Security, Medicare, and pension crises.

Today, those crises loom greater than ever but few seem to know or care. Any politician who tells voters that we must cut spending to prevent bankruptcy is denounced as uncompassionate.

For that reason, I don’t see a political solution to the demographic storm that is ravaging Puerto Rico. The scientific solution is within our grasp but few know that it exists or that we need it.   

For years, John Mauldin and I have pondered how to speed up the scientific innovation that can extend health spans and rescue economies and budgets. We don’t have all the answers yet but I think they’re appearing. Soon, in fact, I’m going to ask for your help on one idea.

Patrick Cox
Patrick Cox
Editor, Transformational Technology Alert

Mauldin Economics


Stay in the Loop on Life-Extending Research
with Patrick Cox's Tech Digest

Tech Digest

Your privacy is very important to us. Please review our Privacy Policy.


« Back to Articles

From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here

Discuss This


We welcome your comments. Please comply with our Community Rules.


Oct. 16, 2017, 5:16 a.m.

For all of the repeat discussion of life extension supplements, precisely what benefit is actually achieved enabling potential workers to be able to work extended careers when a combination of government policies and current employment practices encourage shorter careers and discriminatory hiring practices for people over age 50? Personally, I think too many companies are missing the boat in not actively recruiting and retaining older workers whom can offer years of old-fashioned on-the-job experience and maturity of judgement, particularly during times of crisis.

Rolf H Parta

Oct. 9, 2017, 4:17 p.m.

Defiance of basic economic laws never works out well in the long run.  Puerto Rico has been saddled with such defiance by the US Congress, in collaboration with successive administrations.  Inherent in being an island, Puerto Rico is dependent on cheap ocean shipping for virtually all imports and exports [excluding high value, low volume products such as drugs, which go by air freight].  The Jones Act, a creature of the federal government near 100 years ago, virtually prohibits this in the case of Puerto Rico.  It should be completely repealed.

Other Federal laws have severe negative consequences on Puerto Rico as well.  The federal $7.25 minimum wage law keeps costs for PR vacations higher than those of vacations in competing Caribbean resorts.  Refusal of Congress to allow the Commonwealth to go bankrupt fueled excessive borrowing by reducing perceived risk to lenders.  These policies also need to be rescinded if Puerto Rico is to rise from the ashes.

Even Patrick Cox’ dreamed of increases in useful working lifetimes won’t help Puerto Rico if the cost of the treatments is neither cheap [so PR residents can afford them] nor paid by the federal government.  And you can be certain sure that the various companies whose efforts Cox touts regularly are for profit entities which assures that first call on their products [if and after FDA approval] will go to the well to do. —which surely isn’t the ordinary citizen of Puerto Rico.

Frankly, given the massive inertia of our federal government, I think Puerto Rico would probably be better off to declare independence, boot the US laws and overseers off the island, and start over as a free and independent people [who, incidentally, will repudiate their bonded debts and devalue their currency severely].

Newell Franks

Oct. 9, 2017, 2:40 p.m.

The companies you mention in this article had the technical knowledge to build facilities and infrastructure that was hurricane rated. They could have explained to shareholders why they were making the investment. Had they done the right thing they could now go before the same shareholders with a great success story to tell. Their facilities could have been anchor locations that helped the island to recover from the storm had they done the right thing when building those facilities. Preparedness and self reliance are principles individuals, families, and companies should all practice!

Use of this content, the Mauldin Economics website, and related sites and applications is provided under the Mauldin Economics Terms & Conditions of Use.

Unauthorized Disclosure Prohibited

The information provided in this publication is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. Mauldin Economics reserves all rights to the content of this publication and related materials. Forwarding, copying, disseminating, or distributing this report in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.
Participation in such activity is grounds for immediate termination of all subscriptions of registered subscribers deemed to be involved at Mauldin Economics’ sole discretion, may violate the copyright laws of the United States, and may subject the violator to legal prosecution. Mauldin Economics reserves the right to monitor the use of this publication without disclosure by any electronic means it deems necessary and may change those means without notice at any time. If you have received this publication and are not the intended subscriber, please contact


The Mauldin Economics website, Thoughts from the Frontline, The Weekly Profit, The 10th Man, Connecting the Dots, Transformational Technology Digest, Over My Shoulder, Yield Shark, Transformational Technology Alert, Rational Bear, Street Freak, ETF 20/20, In the Money, and Mauldin Economics VIP are published by Mauldin Economics, LLC Information contained in such publications is obtained from sources believed to be reliable, but its accuracy cannot be guaranteed. The information contained in such publications is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. The opinions expressed in such publications are those of the publisher and are subject to change without notice. The information in such publications may become outdated and there is no obligation to update any such information. You are advised to discuss with your financial advisers your investment options and whether any investment is suitable for your specific needs prior to making any investments.
John Mauldin, Mauldin Economics, LLC and other entities in which he has an interest, employees, officers, family, and associates may from time to time have positions in the securities or commodities covered in these publications or web site. Corporate policies are in effect that attempt to avoid potential conflicts of interest and resolve conflicts of interest that do arise in a timely fashion.
Mauldin Economics, LLC reserves the right to cancel any subscription at any time, and if it does so it will promptly refund to the subscriber the amount of the subscription payment previously received relating to the remaining subscription period. Cancellation of a subscription may result from any unauthorized use or reproduction or rebroadcast of any Mauldin Economics publication or website, any infringement or misappropriation of Mauldin Economics, LLC’s proprietary rights, or any other reason determined in the sole discretion of Mauldin Economics, LLC.

Affiliate Notice

Mauldin Economics has affiliate agreements in place that may include fee sharing. If you have a website or newsletter and would like to be considered for inclusion in the Mauldin Economics affiliate program, please go to Likewise, from time to time Mauldin Economics may engage in affiliate programs offered by other companies, though corporate policy firmly dictates that such agreements will have no influence on any product or service recommendations, nor alter the pricing that would otherwise be available in absence of such an agreement. As always, it is important that you do your own due diligence before transacting any business with any firm, for any product or service.

© Copyright 2018 Mauldin Economics